Skip to main content
. 2012 May;23(5):959–965. doi: 10.1681/ASN.2011070740

Table 1.

Medicare ESRD beneficiary drug coverage by beneficiary characteristics

Characteristic Source of Coverage
Estimated Population, n No Known Coverage Part D (No LIS) Part D (LIS) Former Employer Other Creditable
ESRD Non-ESRD ESRD Non-ESRD ESRD Non-ESRD ESRD Non-ESRD ESRD Non-ESRD ESRD Non-ESRD
All 432,845 43,884,880 17.0 15.4a,b 18.3 34.0a,b 46.0 21.7a,b 9.0 15.9a,b 9.7 13.0a,b
Age (yr)
 20–44 67,025 1,731,315 22.3c 14.5a,b 5.8c 6.4a 66.3c 72.4a,b 0.7c 0.6 4.9c 6.1a,b
 45–64 178,230 5,537,750 24.2c 17.8a,b 12.0c 17.9a,b 49.4c 43.8a,b 4.9c 5.3a,b 9.5c 15.2a,b
 65–74 104,125 19,051,650 9.1c 16.2a,b 27.1c 37.6a,b 38.7c 14.0a,b 14.1c 17.5a,b 11.0c 14.6a,b
 ≥75 83,465 17,564,165 7.2c 13.8a,b 30.5c 38.0a,b 31.8c 18.2a,b 17.9c 19.0a,b 12.6c 11.2a,b
Sex
 men 243,855 19,439,940 17.3 14.4a,b 19.1 31.5a,b 41.2 18.6a,b 9.4 16.2a,b 13.0 19.3a,b
 women 188,990 24,444,940 16.7 16.1a 17.2 36.0a,b 52.2 24.2a,b 8.4 15.7a,b 5.5 7.9a,b
Race/ethnicity
 white 200,975 34,373,450 18.5c 15.0a,b 25.0c 36.7a,b 31.0c 16.4a,b 12.5c 18.0a,b 13.0c 13.9a,b
 black 136,735 4,183,725 12.0c 13.4a,b 12.0c 19.8a,b 60.7c 43.9a,b 7.8c 11.7a,b 7.5c 11.1a,b
 Hispanic 59,690 3,308,160 16.2c 16.2 13.2c 31.0 a,b 62.3c 40.2a,b 3.3c 5.2a,b 5.1c 7.4a,b
 Asian/PI 15,095 1,023,090 17.1c 12.6a,b 17.6c 26.5a,b 55.0c 46.3a,b 3.3c 5.8a,b 7.0c 8.8a,b
 AI/AN 4835 168,740 18.7c 21.9a 6.7c 15.3a,b 63.5c 44.8a,b 1.7c 5.4a,b 9.4c 12.6a
 other/
 unknown 15,515 827,715 44.5c 39.9a,b 9.5c 20.5a,b 35.1c 19.7a,b 3.3c 7.4a,b 7.4c 12.6 a,b

Data are derived from the Centers for Medicare and Medicaid CCW 20% sample. Source of coverage, Medicare eligibility, and ESRD status were ascertained in December 2007. Each observation is weighted by 5 to give population estimates. Unless otherwise indicated, values are percentages. AI/AN, American Indian/Alaska Native; LIS, low-income subsidy; PI, Pacific Islander.

a

Differences between estimate for ESRD population and non-ESRD population significant at the P<0.05 confidence level.

b

Differences between estimate for ESRD population and non-ESRD population significant at the P<0.05 level after Bonferroni correction.

c

Significant deviations from the expected value for the population in the distributions of beneficiary characteristics within coverage groups based on chi-squared tests (P<0.05).